DONG ZHOU

DONG ZHOU

University of Connecticut

H-index: 29

North America-United States

About DONG ZHOU

DONG ZHOU, With an exceptional h-index of 29 and a recent h-index of 28 (since 2020), a distinguished researcher at University of Connecticut, specializes in the field of Kidney disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

Proteome characterization of liver–kidney comorbidity after microbial sepsis

Calponin 2 regulates ketogenesis to mitigate acute kidney injury

Understanding the interplay between N6‐methyladenine RNA methylation and noncoding RNAs in kidney disease

Jumonji domain‐containing protein‐3 (JMJD3) promotes myeloid fibroblast activation and macrophage polarization in kidney fibrosis

Calponin 2 harnesses metabolic reprogramming to determine kidney fibrosis

JMJD3 Promotes Myeloid Fibroblast Activation and Macrophage Polarization in Kidney Fibrosis.

Acute kidney injury in diabetes mellitus: Epidemiology, diagnostic, and therapeutic concepts

Tissue microenvironment in kidney diseases

DONG ZHOU Information

University

Position

School of Medicine

Citations(all)

3756

Citations(since 2020)

2708

Cited By

2106

hIndex(all)

29

hIndex(since 2020)

28

i10Index(all)

43

i10Index(since 2020)

42

Email

University Profile Page

Google Scholar

DONG ZHOU Skills & Research Interests

Kidney disease

Top articles of DONG ZHOU

Proteome characterization of liver–kidney comorbidity after microbial sepsis

The FASEB Journal

2024/4/15

Understanding the interplay between N6‐methyladenine RNA methylation and noncoding RNAs in kidney disease

Clinical and Translational Discovery

2023/10

Jumonji domain‐containing protein‐3 (JMJD3) promotes myeloid fibroblast activation and macrophage polarization in kidney fibrosis

British Journal of Pharmacology

2023/9

Calponin 2 harnesses metabolic reprogramming to determine kidney fibrosis

Molecular Metabolism

2023/5/1

JMJD3 Promotes Myeloid Fibroblast Activation and Macrophage Polarization in Kidney Fibrosis.

British Journal of Pharmacology

2023/4/19

Acute kidney injury in diabetes mellitus: Epidemiology, diagnostic, and therapeutic concepts

2023/4

Tissue microenvironment in kidney diseases

2023/2/6

Causal effects of specific gut microbiota on chronic kidney diseases and renal function—A two-sample Mendelian randomization study

Nutrients

2023/1/11

Histone deacetylase 3 plays a critical role in hypertension-induced kidney inflammation and fibrosis

bioRxiv

2023

Limonin, a natural ERK2 agonist, protects against ischemic acute kidney injury

International Journal of Biological Sciences

2023

Fibroblast-selective smoothened governs the prognosis of acute kidney injury

2022/9/6

Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis

Kidney international

2022/7/1

CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling

Theranostics

2022

Myeloid PTEN deficiency aggravates renal inflammation and fibrosis in angiotensin II‐induced hypertension

Journal of cellular physiology

2022/1

STAT6 deficiency attenuates myeloid fibroblast activation and macrophage polarization in experimental folic acid nephropathy

Cells

2021/11/6

Effects of SGLT2 inhibitors on renal outcomes in patients with chronic kidney disease: a meta-analysis

2021/11/1

The hepatocyte growth factor/c-met pathway is a key determinant of the fibrotic kidney local microenvironment

Iscience

2021/10/22

Pharmacological inhibition of STAT6 ameliorates myeloid fibroblast activation and alternative macrophage polarization in renal fibrosis

Frontiers in Immunology

2021/8/26

See List of Professors in DONG ZHOU University(University of Connecticut)

Co-Authors

academic-engine